Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Clinical trial NCT06192615 · RECRUITING
Trial details
- NCT number
- NCT06192615
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-06
- Primary completion
- 2027-10-31
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.